323 related articles for article (PubMed ID: 23740149)
1. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
[TBL] [Abstract][Full Text] [Related]
2. A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer.
Ding X; Hui Z; Dai H; Fan C; Men Y; Ji W; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Lu N; He J; Wang L
J Thorac Oncol; 2016 Sep; 11(9):1565-73. PubMed ID: 27223457
[TBL] [Abstract][Full Text] [Related]
3. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
[TBL] [Abstract][Full Text] [Related]
4. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of the Currently Used Nodal Stage Classification with the Number of Metastatic Lymph Nodes and the Number of Metastatic Lymph Node Stations for Non-Small Cell Lung Cancer; Which of These Is the Best Prognostic Factor?
Citak N; Aksoy Y; Isgörücü Ö; Obuz C; Acikmese B; Buyukkale S; Metin M; Sayar A
Zentralbl Chir; 2020 Dec; 145(6):565-573. PubMed ID: 31648357
[TBL] [Abstract][Full Text] [Related]
6. Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes.
Liu H; Yan T; Zhang T; Chen X; Wang Y; Du J
Medicine (Baltimore); 2019 May; 98(20):e15645. PubMed ID: 31096486
[TBL] [Abstract][Full Text] [Related]
7. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC.
Katsumata S; Aokage K; Ishii G; Nakasone S; Sakai T; Okada S; Miyoshi T; Tane K; Tsuboi M
J Thorac Oncol; 2019 Aug; 14(8):1408-1418. PubMed ID: 31055075
[TBL] [Abstract][Full Text] [Related]
9. A hypothesized TNM staging system based on the number and location of positive lymph nodes may better reflect the prognosis for patients with NSCLC.
Shang X; Liu J; Li Z; Lin J; Wang H
BMC Cancer; 2019 Jun; 19(1):591. PubMed ID: 31208403
[TBL] [Abstract][Full Text] [Related]
10. Incorporating the Number of PLN into the AJCC Stage Could Better Predict the Survival for Patients with NSCLC: A Large Population-Based Study.
Shang X; Li Z; Lin J; Yu H; Zhao C; Wang H; Sun J
J Oncol; 2020; 2020():1087237. PubMed ID: 33381175
[TBL] [Abstract][Full Text] [Related]
11. Metastasis to subsegmental and segmental lymph nodes in patients resected for non-small cell lung cancer: prognostic impact.
Rena O; Boldorini R; Papalia E; Turello D; Massera F; Davoli F; Roncon A; Baietto G; Casadio C
Ann Thorac Surg; 2014 Mar; 97(3):987-92. PubMed ID: 24480258
[TBL] [Abstract][Full Text] [Related]
12. Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).
Osarogiagbon RU; Decker PA; Ballman K; Wigle D; Allen MS; Darling GE
Ann Thorac Surg; 2016 Aug; 102(2):363-9. PubMed ID: 27262908
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
14. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
Fukui T; Mori S; Yokoi K; Mitsudomi T
J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with non-small cell lung cancer according to lymph node disease: single pN1 vs multiple pN1 vs single unsuspected pN2.
Macia I; Ramos R; Moya J; Rivas F; Ureña A; Banque M; Escobar I; Rosado G; Rodriguez-Taboada P
Ann Surg Oncol; 2013 Jul; 20(7):2413-8. PubMed ID: 23378017
[TBL] [Abstract][Full Text] [Related]
17. Number of metastatic lymph nodes and zones as prognostic factors in non-small-cell lung cancer.
Maniwa T; Ohmura A; Hiroshima T; Ike A; Kimura T; Nakamura H; Nakatsuka SI; Okami J; Higashiyama M
Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):305-314. PubMed ID: 32728705
[TBL] [Abstract][Full Text] [Related]
18. Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.
Fan Y; Du Y; Sun W; Wang H
Int J Clin Oncol; 2019 Nov; 24(11):1359-1366. PubMed ID: 31183778
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of node involvement pattern in pulmonary pN1 squamous cell carcinoma patients.
Nakao M; Yoshida J; Ishii G; Hishida T; Nishimura M; Nagai K
J Thorac Oncol; 2010 Apr; 5(4):504-9. PubMed ID: 20104192
[TBL] [Abstract][Full Text] [Related]
20. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
